INHIBITION OF THE HIV 1 REV TRANSACTIVATOR
INHIBITION OF THE HIV 1 REV TRANSACTIVATOR
批准号:
2390380
负责人:
ADRIANA HEGUY
金额:
$33.67万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 1998-09-30
中文摘要
该项目的目标是鉴定HIV-1 Rev的新型抑制剂
英文摘要
The goal of this project is to identify novel inhibitors of the HIV-1 Rev
protein for the treatment of AIDS. Rev function is absolutely required
for HIV replication. In Phase I, we constructed a reporter plasmid
containing the luciferase gene between the HIV-1 exon 6 and exon 7 splice
donor and acceptor sites. In this construct, luciferase is expressed only
in the presence of Rev. A transient co-transfection assay has been
adapted for automated high throughput screening. In Phase II, a fully
automated high-throughput screen of 100,000 samples will be carried out,
including 50,000 fungal extracts and an equal number of compounds from
a medicinal chemistry library. Potential Rev inhibitors will cause a
decrease in luciferase activity. Several follow-up assays will be
utilized to qualify lead compounds which act specifically on Rev and to
exclude cytotoxic compounds. Lead organisms will be refermented, the lead
moiety purified and its structure elucidated. The mechanism of action of
those entities exhibiting specific Rev-inhibitory properties, e.g.
inhibition of Rev-RRE interactions or interaction with cellular factors,
will be investigated in vitro. Specific Rev inhibitor lead extracts and
compounds will be tested in HIV replication assay systems, representing
acute and chronic stages of viral infection. In Phase III, selected leads
will be subjected to SAR chemistry and entered into pre-clinical and
clinical development.
PROPOSED COMMERCIAL APPLICATION: Currently there is no effective therapy
for AIDS. Small molecular weight inhibitors of the HIV-1 Rev
transactivator, identified as a result of this project, have significant
potential as anti-viral agents in the treatment of AIDS.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2741/a191
发表时间:
1997-06
期刊:
Frontiers in bioscience : a journal and virtual library
影响因子:
--
作者:
[A. Heguy]
通讯作者:
A. Heguy
Core 1: Genomics Core
-
批准号:10153725
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2019
-
负责人:ADRIANA HEGUY
-
依托单位:
Core 1: Genomics Core
-
批准号:10402275
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2019
-
负责人:ADRIANA HEGUY
-
依托单位:
Core 1: Genomics Core
-
批准号:10652288
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2019
-
负责人:ADRIANA HEGUY
-
依托单位:
The PacBio Sequel for Single Molecule, Real-Time, Long Read Sequencing
-
批准号:9273113
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2017
-
负责人:ADRIANA HEGUY
-
依托单位:
CORE--Gene Expression Analysis
-
批准号:7394179
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2007
-
负责人:ADRIANA HEGUY
-
依托单位:
Genome Technology Center Shared Resource
-
批准号:10608992
-
项目类别:
-
资助金额:$4.78万
-
财政年份:1997
-
负责人:ADRIANA HEGUY
-
依托单位:
INHIBITION OF HIV1 NEF-SH3 INTERACTIONS
-
批准号:2421642
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:ADRIANA HEGUY
-
依托单位:
Genome Technology Center Shared Resource
-
批准号:10358543
-
项目类别:
-
资助金额:$4.78万
-
财政年份:1997
-
负责人:ADRIANA HEGUY
-
依托单位:
TRANSCRIPTIONAL REGULATION OF THROMBOPOIETIN
-
批准号:2150822
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:ADRIANA HEGUY
-
依托单位:
DISCOVERY OF NEW CHEMICAL ENTITIES THAT INHIBIT NEF
-
批准号:3489868
-
项目类别:
-
资助金额:$8.1万
-
财政年份:1994
-
负责人:ADRIANA HEGUY
-
依托单位:
INHIBITION OF THE HIV 1 REV TRANSACTIVATOR
-
批准号:2069834
-
项目类别:
-
资助金额:$36.56万
-
财政年份:1994
-
负责人:ADRIANA HEGUY
-
依托单位:
CORE--Gene Expression Analysis
-
批准号:8234986
-
项目类别:
-
资助金额:$33.62万
-
财政年份:--
-
负责人:ADRIANA HEGUY
-
依托单位:
CORE--Gene Expression Analysis
-
批准号:8114927
-
项目类别:
-
资助金额:$33.62万
-
财政年份:--
-
负责人:ADRIANA HEGUY
-
依托单位:
海外基金